跳至主要内容
临床试验/ISRCTN12951626
ISRCTN12951626已完成不适用

A pilot study of platelet-rich plasma (PRP) versus autologous whole blood versus saline in the treatment of resistant tennis elbow

The Robert Jones and Agnes Hunt Orthopaedic Hospital NHS Foundation Trust0 个研究点目标入组 30 人开始时间: 2015年7月16日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Established lateral epicondyle tendinopathy with a minimum symptom duration of 3 months
  • 2. Aged 18 or above and below 65
  • 3. Willing to avoid the use of topical and oral nonsteroidal anti-inflammatory drugs for a period of 6 weeks following injection
  • 4. Has completed the study physiotherapy program for a minimum period of 6 weeks with no improvement in symptoms
  • Target Gender: Male & Female; Upper Age Limit 65 years ; Lower Age Limit 18 years

排除标准

  • 1. Bilateral tennis elbow
  • 2. Currently taking part in any interventional study that may impact upon study outcomes.
  • 3. A concomitant injury that may impact on the ability to complete outcome assessments
  • 4. Previous surgical intervention of the tendinopathy
  • 5. Inflammatory disease, or chronic widespread pain syndrome
  • 6. Requires regular use of anti-inflammatory medication for complaints other than Tennis Elbow
  • 7. Known platelet dysfunction or thrombocytopaenia, or haemodynamic instability
  • 8. Malignancy
  • 9. Unable or unwilling to complete the 12 month follow-up assessments
  • 10. Unable to communicate fluently in English or an inability to respond to validated questionnaires written in the English language
  • 11. Platelet count <105/microlitre
  • 12. Corticosteroid injection at the treatment site within the last 4 weeks, or systemic use of corticosteroids within the last 2 weeks. Anti-coagulation therapy within 5 days before treatment
  • 13. Treatment with Non-steroidal anti-inflammatory drugs within 1 week prior to treatment
  • 14. Septicaemia or fever

研究者

相似试验